Juniper Biosciences
PrivateLast Round
Seed
Dec 1, 2025
Total Funding Raised
$40M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Juniper Biosciences is a biotechnology company that develops innovative radiopharmaceutical agents for the diagnosis and treatment of cancer and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Juniper Biosciences Comparables
Compare Juniper Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nura Health | 86% | |
| DotLab | 86% | |
| NextGen Jane | 84% |
Juniper Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 1, 2025 |
Key People
Founding team and executive leadership
Juniper Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Club degli Investitori | Seed |
| NovaCapital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 239% MoM, from 342 to 1.2K.
- Aug 16, 2026
Grew 43% QoQ from 7 to 10 employees.
Juniper Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Juniper Biosciences's valuation, stock price, and market status.
Is Juniper Biosciences a public or private company?
Juniper Biosciences is a private company.
What is the current stock price of Juniper Biosciences?
Juniper Biosciences is a private company with no public stock price. Caplight tracks Juniper Biosciences's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Juniper Biosciences worth (valuation)?
Valuation information for Juniper Biosciences is not publicly available.
Can I buy Juniper Biosciences stock?
Juniper Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Juniper Biosciences's last funding round?
Juniper Biosciences's most recent funding round was Seed on December 1, 2025.
Who are the main investors in Juniper Biosciences?
Key investors in Juniper Biosciences include Club degli Investitori, NovaCapital.
Will Juniper Biosciences IPO soon?
No public IPO plans have been announced for Juniper Biosciences.
How can I track Juniper Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Juniper Biosciences's secondary market activity and sign up for updates.